Show Summary Details
Page of

HPSE2, LRIG2, and the Urofacial Syndrome 

HPSE2, LRIG2, and the Urofacial Syndrome
HPSE2, LRIG2, and the Urofacial Syndrome

Helen M. Stuart

, Adrian S. Woolf

, and William G. Newman

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 March 2021

Urofacial syndrome (UFS; MIM: 236730), also called Ochoa syndrome, is a rare autosomal recessive disorder. It is genetically heterogeneous due to biallelic loss-of-function mutations in HPSE2 or LRIG2 and with evidence of further heterogeneity. UFS is characterized by abnormal neuromuscular function affecting the lower urinary tract, gastrointestinal tract and the distribution of the facial nerve. Urinary tract features include non-neurogenic bladder voiding dysfunction with risk of vesicoureteric reflux, hydroureteronephrosis and end stage renal failure. Lower gastrointestinal features include constipation and encopresis. There is variable weakness in the distribution of the facial nerve and an abnormality of facial movement typically described as a ‘grimace’ due to abnormal co-contraction of the corners of the mouth and eyes with expression. It is this extra-renal feature that distinguishes UFS from other causes of elimination dysfunction.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.